Altered prepulse inhibition in rats treated prenatally with the antimitotic Ara-C: an animal model for sensorimotor gating deficits in schizophrenia

By Elmer G.   Sydnor J.   Guard H.   Hercher E.   Vogel M.  

Psychopharmacology, Vol. 174, Iss. 2, 2004-07 ,pp. : 177-189

Springer Publishing Company

Access to resources Recommend Favorite

Dose Response and Atypical Antipsychotics in Schizophrenia

By Kinon B.J.  

CNS Drugs, Vol. 18, Iss. 9, 2004-01 ,pp. : 597-616

Adis International

Access to resources Recommend Favorite

CRF1 receptor antagonists do not reverse pharmacological disruption of prepulse inhibition in rodents

By Douma T.   Millan M.   Boulay D.   Griebel G.   Verdouw P.   Westphal K.   Olivier B.   Groenink L.  

Psychopharmacology, Vol. 231, Iss. 7, 2014-04 ,pp. : 1289-1303

Springer Publishing Company

Access to resources Recommend Favorite

The relative prescribing rate of atypical antipsychotics for patients with schizophrenia and other psychotic disorders "nearly doubled" in general practice between 1998 and 2002

By  

Inpharma, Vol. 1, Iss. 1389, 2003-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Combined α-adrenergic/D dopamine receptor blockade fails to reproduce the ability of clozapine to reverse phencyclidine-induced deficits in prepulse inhibition of startle

By Ballmaier Martina   Zoli Michele   Mazzoncini Rodolfo   Gennarelli Massimo   Spano Pier  

Psychopharmacology, Vol. 159, Iss. 1, 2001-12 ,pp. : 105-110

Springer Publishing Company

Access to resources Recommend Favorite